Related Experiment Videos
Peribiliary myofibroblasts in biliary type liver fibrosis
Nils Kinnman1, Chantal Housset
1Department of Gastroenterology and Hepatology, Karolinska Hospital, Karolinska Institute, 171 76 Stockholm, Sweden. nils.kinnman@ks.se
Frontiers in Bioscience : a Journal and Virtual Library
|January 30, 2002
Summary
Liver fibrosis involves myofibroblasts near bile ducts. Bile duct epithelial cells and peribiliary myofibroblasts drive this fibrotic response in cholestatic liver injury.
Area of Science:
- Hepatology
- Fibrosis Research
- Cell Biology
Background:
- Biliary fibrosis is a response to bile duct injury in cholestatic liver diseases.
- The source of myofibroblasts in ductular reactions during cholestasis is debated.
- Hepatic stellate cells and portal fibroblasts are potential sources of myofibroblasts.
Purpose of the Study:
- To investigate the origin of myofibroblasts in biliary type liver fibrosis.
- To understand the role of bile duct epithelial cells in fibrogenesis.
- To elucidate the mechanisms driving periportal fibrosis in cholestatic liver injury.
Main Methods:
- Studies primarily utilized the rat bile duct ligation model.
- Morphological analyses were employed to assess cell origins.
- Investigated paracrine mediator release by bile duct epithelial cells.
Main Results:
- Evidence suggests hepatic stellate cells transform into myofibroblasts and are chemoattracted to bile ducts.
- Morphological studies also implicated activated portal fibroblasts.
- Bile duct epithelial cells release mediators like TGF-β, CTGF, PDGF-BB, and endothelin-1.
Conclusions:
- Bile duct epithelial cells actively regulate biliary fibrogenesis.
- These cells and peribiliary myofibroblasts contribute to periportal fibrosis.
- Findings are relevant to cholestatic and potentially other liver diseases.